MRI-guided photothermal/photodynamic immune activation combined with PD-1 inhibitor for the multimodal combination therapy of melanoma and metastases.

* P < 0.05 was considered significant; ** P < 0.01 represents a highly significant difference between groups; and ** P < 0.001 represents an extremely significant difference between groups.

also in 132,142 other papers